Humax-IL 15 Uses, Dosage, Side Effects and more
Humax-IL 15 is under investigation in clinical trial NCT02633020 (Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease).
| Attribute | Details |
|---|---|
| Trade Name | Humax-IL 15 |
| Generic | Ordesekimab |
| Ordesekimab Other Names | Human IgG1 anti-IL-15 monoclonal antibody, Humax IL15, Humax-IL 15 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
